FRANKLIN, Tenn.--(BUSINESS WIRE)--May. 21, 2012--
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company”) today
announced the closing of its previously announced registered follow-on
offering of 8,250,000 shares of its common stock at a public offering
price of $15.50 per share. Prior to closing, the underwriters exercised
in full their option to purchase an additional 1,237,500 shares of
common stock from the Company. As a result, the total offering size was
9,487,500 shares of common stock.
Acadia received approximately $139 million in net proceeds from the
offering, after deducting underwriting discounts and commissions and
estimated expenses of the offering. Acadia expects to use the net
proceeds from this offering principally to fund its acquisition
strategy. The Company plans to use the net proceeds for general
corporate purposes to the extent not used for acquisitions.
Citigroup, BofA Merrill Lynch and Jefferies & Company, Inc. acted as
joint bookrunners for the offering, and Raymond James & Associates,
Inc., RBC Capital Markets, LLC and Avondale Partners, LLC acted as
co-managers. The offering was made only by means of a written
prospectus, copies of which may be obtained by contacting: Citigroup,
Attention: Prospectus Department, Brooklyn Army Terminal, 140 East 58th
Street, 8th Floor, Brooklyn, NY 11220 or telephone: (800) 831-9146 or
email: BATProspectusdept@citi.com;
BofA Merrill Lynch, Attn: Prospectus Department, 4 World Financial
Center, New York, NY 10080 or email: dg.prospectus_requests@baml.com;
or from Jefferies & Company, Inc., 520 Madison Ave., 12th Floor, New
York, NY 10022, Attn: Equity Syndicate Prospectus Department or
telephone (877) 547-6340 or email Prospectus_Department@Jefferies.com.
A registration statement relating to these shares of common stock of the
Company was declared effective by the Securities and Exchange Commission
(the “SEC”) on May 15, 2012. The final prospectus may also be obtained
on the SEC’s website at http://www.sec.gov.
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy, nor shall there be any sale of these
securities in any state or jurisdiction in which such an offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
Forward-Looking Statements
This news release contains forward-looking statements. Generally words
such as “may,” “will,” “should,” “could,” “anticipate,” “expect,”
“intend,” “estimate,” “plan,” “continue,” and “believe” or the negative
of or other variation on these and other similar expressions identify
forward-looking statements. These forward-looking statements are made
only as of the date of this news release. The Company does not undertake
to update or revise the forward-looking statements, whether as a result
of new information, future events or otherwise. Forward-looking
statements are based on current expectations and involve risks and
uncertainties and Acadia’s future results could differ significantly
from those expressed or implied by the forward-looking statements.
About Acadia
Acadia is a provider of inpatient behavioral health care services.
Acadia operates a network of 33 behavioral health facilities with
approximately 2,150 licensed beds in 19 states. Acadia provides
psychiatric and chemical dependency services to its patients in a
variety of settings, including inpatient psychiatric hospitals,
residential treatment centers, outpatient clinics and therapeutic
school-based programs.
Source: Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc.
Brent Turner, President,
615-861-6000
